IP Verse

Cell Line Overexpressing Human Cd303 Antigen

Patent No. EP3277723 (titled "Cell Line Overexpressing Human Cd303 Antigen") was filed by Laboratoire Franais DU Fractionnement ET DES Biotechnologies on Mar 31, 2016. The application was issued on Jun 17, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
POHLMANMar 17, 2021POHLMAN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3277723

LABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Application Number
EP16714843A
Filing Date
Mar 31, 2016
Status
Granted And Under Opposition
May 15, 2020
Publication Date
Jun 17, 2020
External Links
Slate, Register , Google Patents